PReS-FINAL-2144: Bone mineral status in patients with juvenile idiopathic arthritis after 12 months of treatment with etanercept

被引：0
|
作者：
G Susic
G Radunovic
N Damjanov
D Novakovic
N Djurovic
R Stojanovic
机构：
[1] Institute of Rheumatology,
[2] University of Belgrade,undefined
[3] School of Medicine,undefined
来源：
Pediatric Rheumatology | / 11卷 / Suppl 2期
关键词：
Bone Mineral Density; Osteoporosis; Bone Mineral; Lumbar Spine; Etanercept;
D O I：
10.1186/1546-0096-11-S2-P156
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 39 条
  • [1] Bone mineral density improvement after one year of treatment with etanercept in patients with juvenile idiopathic arthritis
    G Susic
    R Stojanovic
    N Damjanov
    J Vojinovic
    G Vijatov
    Pediatric Rheumatology, 6 (Suppl 1)
  • [2] Bone mineral density in children with juvenile idiopathic arthritis after one year of treatment with etanercept
    Susic, Gordana
    Atanaskovic, Marija
    Stojanovic, Roksanda
    Radunovic, Goran
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2018, 146 (5-6) : 297 - 302
  • [3] Bone status over 1 yr of etanercept treatment in juvenile idiopathic arthritis
    Simonini, G
    Giani, T
    Stagi, S
    de Martino, M
    Falcini, F
    RHEUMATOLOGY, 2005, 44 (06) : 777 - 780
  • [4] PReS-FINAL-2096: Herpes virus infections in patients with juvenile idiopathic arthritis (JIA) treated with etanercept
    R Nicolai
    E Cortis
    L Ravà
    C Bracaglia
    M Pardeo
    A Insalaco
    PS Buonuomo
    F De Benedetti
    AE Tozzi
    Pediatric Rheumatology, 11 (Suppl 2)
  • [5] Bone mineral density in patients with juvenile idiopathic arthritis
    Garcell., Alejandro Jesus Bermudez
    Gamez., Nilvia Bienvenida Serrano
    Gines., Rolando Teruel
    Montero., Maria de los angeles Leyva
    REVISTA CUBANA DE REUMATOLOGIA, 2024, 26
  • [6] Bone Mineral Density in Patients with Juvenile Idiopathic Arthritis
    Susic, Gordana
    Pilipovic, Nada
    Stojanovic, Roksanda
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2009, 137 (7-8) : 396 - 401
  • [7] PReS-FINAL-2016: Bone mineral status in a long-term follow up of juvenile dermatomyositis patients
    VA Kristensen
    S Nielsen
    T Herlin
    P Mathiesen
    Pediatric Rheumatology, 11 (Suppl 2)
  • [8] PReS-FINAL-2142: Predictors of persistent remission following etanercept (ETN) withdrawal in patients with juvenile idiopathic arthritis (JIA)
    F Perfetti
    F Gesualdo
    V Messia
    A Insalaco
    C Bracaglia
    M Pardeo
    R Nicolai
    L Meli
    F De Benedetti
    S Magni Manzoni
    Pediatric Rheumatology, 11 (Suppl 2)
  • [9] PReS-FINAL-2145: MRP8/14 serum complexes as predictor of response to etanercept treatment in juvenile idiopathic arthritis
    J Anink
    MH Otten
    LA Van Suijlekom-Smit
    MA Van Rossum
    KM Dolman
    EP Hoppenreijs
    R Ten Cate
    T Vogl
    D Foell
    J Roth
    D Holzinger
    Pediatric Rheumatology, 11 (Suppl 2)
  • [10] When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritis
    FHM Prince
    M Twilt
    SCM Simon
    MAJ van Rossum
    W Armbrust
    EPAH Hoppenreijs
    SSM Kamphuis
    M van Santen-Hoeufft
    Y Koopman-Keemink
    N Wulffraat
    R ten Cate
    LWA van Suijlekom-Smit
    Pediatric Rheumatology, 6 (Suppl 1)
1234